AstraZeneca Says U.S. Nexium Safe With Product From Banned Plant

Nexium pills made with an ingredient from an Indian plant that failed regulatory inspections are safe to use and haven’t been removed from the U.S. marketplace, AstraZeneca Plc said.

Nexium, the acid-reflux medicine, generated $3.9 billion in sales last year as AstraZeneca’s second best-selling drug. While the company previously bought a key ingredient for Nexium sold in the U.S. from Ranbaxy Laboratories Ltd. in India and Minakem of France, it switched to the French company as sole supplier after regulators banned Ranbaxy in January from sending products from the plant to the U.S.

The quality of drugs made in some ...